Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia

Leuk Res. 2022 Oct:121:106923. doi: 10.1016/j.leukres.2022.106923. Epub 2022 Aug 4.
No abstract available

Keywords: Accelerated phase; Chronic myeloid leukemia; Dose reduction; Tyrosine kinase inhibitor.

Publication types

  • Letter

MeSH terms

  • Drug Tapering*
  • Humans
  • Leukemia, Myeloid, Accelerated Phase
  • Leukemia, Myeloid, Chronic-Phase* / drug therapy
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Protein Kinase Inhibitors